New York, NY, May 02, 2018 -- NEW YORK, May 2, 2018 / / — Edgar Agents, the full-service SEC filing agency for public companies, private equity firms, and securities law firms, today announced that the company will be presenting their Capital Markets and Corporate Services solutions at the 2018 Disruptive Growth & Healthcare Conference on May 8-9, 2018.
The event is held in the NYC offices of Read Smith, LLC. http://disruptnyc.com/
In 2017, 33% of the RegA+ issuers that listed on the NYSE and NASDAQ worked with Edgar Agents. Additionally, the company is an authority on quarterly and periodic EDGAR filing processes, and is the only financial printer to offer an Abort Fee Structure with a guaranteed rate cap.
Throughout the 2018 Disruptive Growth & Healthcare Conference, Edgar Agents will offer guidance on:
- Cost-effective EDGAR and XBRL programs
- Shareholder communications, including news distribution
- Regulation A+ (mini-IPO) registrations
- S-1 and secondary offering transactions
- Virtual Data Rooms
- More
Edgar Agents’ solutions are especially tailored for micro-cap to mid-cap corporations, and their investment bankers and securities law firms. To keep up-to-date on Edgar Agents’ continued growth, please follow the company in LinkedIn HERE.
Please visit Edgar Agents today for more information: www.edgaragents.com
About Edgar Agents, LLC
At Edgar Agents, we manage all of your filing needs. From annual 10-Ks and quarterly 10-Qs to 8-Ks, Registration Statements and Section 16 filings, we will provide you with unparalleled customer service, accurate and prompt turn around, all at an incomparably competitive price.
There are no unexpected bills from us. Edgar Agents prides itself on its transparent billing practices. You will receive an invoice within 24 hours of transmission to the Securities and Exchange Commission (SEC) that clearly states what you are paying for and why.
Contact:
Edgar Agents, LLC.
Marketing Dept.
Phone: (212) 265-3347
Email: [email protected]


Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 



